Over the last decade, the field of cell therapy has rapidly grown, and it holds enormous promise for treating many diseases. There are still factors like manufacturing maze, investment, logistics and regulatory challenges which prevents the cell and gene therapies to be widely used. We are once again putting together a unique platform to provide the exact solutions to these robust manufacturing and bioprocessing challenges, at our 3rd Annual MarketsandMarkets Cell & Gene Therapy Manufacturing Virtual Conference.
We have created a virtual engaging model that will be beneficial for speakers, attendees and sponsors/exhibitors, taking place on 28th - 29th October 2021.
Learn from the leading experts of the industry about strategies, technologies and innovations in the area of bioprocessing of cell-gene therapies.
Principal, Advanced Cell & Gene Therapy LLC
Consultant, Cell & Gene Therapy Consulting LLC
Global Leader in Process Development (R &D, CMC), Manufacturing, & Commercialization-, Biotechnology, Biopharmaceuticals
Director of Operations & Business Development, Anemocyte
Founding Director, Chairman of the Board, Agility Pharmaceuticals
Field Application Scientist, Gyros Protein Technologies
Founder & CEO, Adva Biotechnology
Head of Vector and CAR-T Cell Processing, Immuneel Therapeutics Pvt Ltd
Senior Business Development Manager, Cell & Gene Therapy , CPC
Chief Operating Officer, Alphalyse
Senior Product Manager & Application Scientist, Angelantoni Life Science S.r.l.
Vice President , QC & Analytical Development, Vigene Biosciences-A Charles River Company